Literature DB >> 11822885

Effect of allogeneic Schwann cell transplantation on peripheral nerve regeneration.

Afshin Mosahebi1, Paul Fuller, Mikael Wiberg, Giorgio Terenghi.   

Abstract

Transplantation of allogeneic Schwann cells (SC) would make it feasible to reconstruct immediately peripheral nerve defects, compared to using autologous SC; however, this treatment modality has not been adequately evaluated. The aim of this study was to characterize and compare the effects of allogeneic versus syngeneic SC transplantation following peripheral nerve injury. Polyhydroxybutyrate conduits were used to bridge a 10-mm gap in the rat sciatic nerve. The conduits were filled with alginate hydrogel with or without cultured allogeneic or syngeneic genetically labeled SC, without the use of immunosuppressive therapy, and examined after 2, 3, and 6 weeks with 5-bromo-4-chloro-3-indoyl-beta-D-galactosidase chemical staining and immunohistochemistry to quantify SC migration into the conduit, axonal regeneration, the state of SC differentiation, and the expression of major histocompatibility complexes (MHC) I and II, as well as to quantify macrophage and B- and T-lymphocyte infiltration. Allogeneic SC were rejected by 6 weeks, whereas syngeneic SC could still be identified. Allogeneic and syngeneic SC equally enhanced the axonal regeneration distance but the quantity of axons was greater using syngeneic SC. The ingrowth of SC into the conduits containing allogeneic SC was similar to that observed in the presence of syngeneic SC, indicating the absence of deleterious immune response. SC continued to express phenotypic markers of nonmyelination and these were highest in conduits with allogeneic SC. Expression of MHC I and II was higher in the conduits with allogeneic SC at 3 weeks and without significant difference in the number of macrophages and lymphocytes, except at 6 weeks, when there was a larger number of lymphocytes using syngeneic SC. In conclusion, allogeneic SC enhanced axonal regeneration distance and did not induce a deleterious immune response. In a clinical setting the immediate availability of allogeneic SC for transplantation may compensate for the better outcome achieved by the use of autologous SC that require a longer preparation time in culture. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11822885     DOI: 10.1006/exnr.2001.7846

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  39 in total

1.  Efficient generation of schwann cells from human embryonic stem cell-derived neurospheres.

Authors:  Lina Ziegler; Sergei Grigoryan; In Hong Yang; Nitish V Thakor; Ronald S Goldstein
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 2.  Bioengineered nerve regeneration and muscle reinnervation.

Authors:  Paul J Kingham; Giorgio Terenghi
Journal:  J Anat       Date:  2006-10       Impact factor: 2.610

Review 3.  Schwann cells as a therapeutic target for peripheral neuropathies.

Authors:  Helmar C Lehmann; Ahmet Höke
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-12       Impact factor: 4.388

4.  A human hair keratin hydrogel scaffold enhances median nerve regeneration in nonhuman primates: an electrophysiological and histological study.

Authors:  Lauren A Pace; Johannes F Plate; Sandeep Mannava; Jonathan C Barnwell; L Andrew Koman; Zhongyu Li; Thomas L Smith; Mark Van Dyke
Journal:  Tissue Eng Part A       Date:  2013-11-15       Impact factor: 3.845

5.  In vivo application of poly-3-hydroxyoctanoate as peripheral nerve graft.

Authors:  D Burcu Hazer; Ercan Bal; Gülay Nurlu; Kemal Benli; Serdar Balci; Feral Öztürk; Baki Hazer
Journal:  J Zhejiang Univ Sci B       Date:  2013-11       Impact factor: 3.066

6.  Hand allotransplantation.

Authors:  Gerald Brandacher; Vijay S Gorantla; W P Andrew Lee
Journal:  Semin Plast Surg       Date:  2010-02       Impact factor: 2.314

7.  Schwann cells secrete extracellular vesicles to promote and maintain the proliferation and multipotency of hDPCs.

Authors:  Ziyue Li; Yan Liang; Kuangwu Pan; Hui Li; Mei Yu; Weihua Guo; Guoqing Chen; Weidong Tian
Journal:  Cell Prolif       Date:  2017-08       Impact factor: 6.831

8.  Molecular sequelae of topographically guided peripheral nerve repair.

Authors:  Vivek Mukhatyar; Balakrishna Pai; Isaac Clements; Akhil Srinivasan; Richard Huber; Akash Mehta; Shoumit Mukhopadaya; Soumon Rudra; Gaurangkumar Patel; Lohitash Karumbaiah; Ravi Bellamkonda
Journal:  Ann Biomed Eng       Date:  2013-12-20       Impact factor: 3.934

Review 9.  Biomedical Applications of Polyhydroxyalkanoates.

Authors:  Subhasree Ray; Vipin Chandra Kalia
Journal:  Indian J Microbiol       Date:  2017-04-22       Impact factor: 2.461

10.  Schwann cells overexpressing FGF-2 alone or combined with manual stimulation do not promote functional recovery after facial nerve injury.

Authors:  Kirsten Haastert; Maria Grosheva; Srebrina K Angelova; Orlando Guntinas-Lichius; Emmanouil Skouras; Joern Michael; Claudia Grothe; Sarah A Dunlop; Doychin N Angelov
Journal:  J Biomed Biotechnol       Date:  2009-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.